Results 21 to 30 of about 3,935,620 (190)

Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity.

open access: yesJournal of Medicinal Chemistry, 2020
Structure-activity relationships for a series of small-molecule thiophenes resulted in potent and selective antagonism of human Complement C3a receptor. The compounds are about 100-fold more potent than the most reported antagonist SB290157.
J. Rowley   +11 more
semanticscholar   +4 more sources

Regulation of C3a receptor signaling in human mast cells by G protein coupled receptor kinases. [PDF]

open access: yesPLoS ONE, 2011
The complement component C3a activates human mast cells via its cell surface G protein coupled receptor (GPCR) C3aR. For most GPCRs, agonist-induced receptor phosphorylation leads to receptor desensitization, internalization as well as activation of ...
Qiang Guo   +3 more
doaj   +4 more sources

C3a receptor blockade protects podocytes from injury in diabetic nephropathy. [PDF]

open access: yesJCI Insight, 2020
Renal activation of the complement system has been described in patients with diabetic nephropathy (DN), although its pathological relevance is still ill-defined.
Morigi M   +10 more
europepmc   +2 more sources

Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA/2J mice. [PDF]

open access: yesJ Neuroinflammation, 2020
The risk of glaucoma increases significantly with age and exposure to elevated intraocular pressure, two factors linked with neuroinflammation. The complement cascade is a complex immune process with many bioactive end-products, including mediators of ...
Harder JM   +7 more
europepmc   +2 more sources

C3a receptor antagonist therapy is protective with or without thrombolysis in murine thromboembolic stroke. [PDF]

open access: yesBr J Pharmacol, 2020
Intravenous thrombolysis (IVT) after stroke enhances C3a generation, which may abrogate the benefits of reperfusion. The C3aR antagonist SB290157 is neuroprotective following transient but not permanent middle cerebral artery occlusion (MCAo).
Ahmad S   +10 more
europepmc   +2 more sources

Knockout of the C3a receptor protects against renal ischemia reperfusion injury by reduction of NETs formation. [PDF]

open access: yesCell Mol Life Sci, 2023
Wu X   +10 more
europepmc   +2 more sources

C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor [PDF]

open access: yesKidney International, 1999
C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor.BackgroundSome individual components of complement are synthesized by the kidney.
Pussell, Bruce A.   +7 more
core   +4 more sources

Activated human T lymphocytes express a functional C3a receptor [PDF]

open access: yesThe Journal of Immunology, 2000
The C3a molecule is an anaphylatoxin of the C system with a wide spectrum of proinflammatory effects predominantly an cells of myeloid origin. In this study we investigated the expression of the high affinity receptor for C3a (C3aR) in human T ...
Werfel, T.   +7 more
core   +6 more sources

Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a

open access: yesNature Communications, 2017
Complement C3a is an important protein in innate and adaptive immunity, but its roles in vivo are unclear. Here the authors develop novel chemical agonists and antagonists for the C3a receptor, and show that they modulate mast cell degranulation and ...
Rink-Jan Lohman   +13 more
doaj   +2 more sources

C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis. [PDF]

open access: yesMucosal Immunol, 2018
Chronic rhinosinusitis with nasal polyps (CRSwNP) is an inflammatory disease with an unknown etiology. Recent studies have implicated the complement system as a potential modulator of disease immunopathology.
Mulligan JK   +11 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy